Search

everythinglearnresearchcommunity

for

Search:↓

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Taking vitamin B6 corrected a pregnant woman's metabolic disorder, which changed her hair color.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

The issue covers reproductive health topics like cancer markers, incontinence treatments, and the impact of pre-term birth.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Hair growth genes work better with more glucose due to changes in gene-regulating markers.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

The enzyme pyruvate kinase M2 helps hair regrowth and could be a potential treatment for hair loss.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Healthy diet and exercise are important for women with PCOS to manage weight and metabolic issues, and supplements like omega-3, vitamin D, and inositol may help.

Squalene may be a marker for certain types of alopecia.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.